Literature DB >> 22242558

Differences in treatment outcome among marijuana-dependent young adults with and without antisocial personality disorder.

Caroline J Easton1, Lindsay M Oberleitner, Melanie C Scott, Michael J Crowley, Theresa A Babuscio, Kathleen M Carroll.   

Abstract

BACKGROUND: Few studies have addressed comorbid antisocial personality disorder (ASPD) and marijuana dependence in young adults, and results from previous studies are inconsistent.
OBJECTIVES: This study evaluated differences in pretreatment characteristics and treatment outcomes between marijuana-dependent young adults with and without ASPD.
METHODS: Data for this study were derived from a randomized trial, in which marijuana-dependent young adults (n = 136) between 18 and 25 years of age were randomized to four behavioral conditions: (1) MET/CBT with CM, (2) MET/CBT without CM, (3) DC with CM, and (4) DC without CM.
RESULTS: Forty-four percent of the participants met DSM-IV-TR criteria for ASPD. ASPD clients had significantly more lifetime alcohol dependence disorders, marijuana use in the 28 days pretreatment, arrests, and assault and weapon charges compared to those without ASPD. ASPD clients did not differ in retention or substance use outcomes at 8 weeks posttreatment or the 6-month follow-up. In general, both groups had more attendance in the voucher condition, but there were no significant ASPD by treatment interactions.
CONCLUSIONS: These data suggest that marijuana-dependent young adults with comorbid ASPD do not necessarily have poorer retention or substance use outcomes compared with marijuana-dependent young adults who do not have ASPD when treated in a well-defined behavioral therapy protocol. SCIENTIFIC SIGNIFICANCE: Previous research has shown increased risks for clients with comorbid ASPD and marijuana dependence; however, our findings suggest that specialized programs for clients with ASPD may not be necessary if they are provided with empirically supported, structured treatments.

Entities:  

Mesh:

Year:  2012        PMID: 22242558      PMCID: PMC3633215          DOI: 10.3109/00952990.2011.643989

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  25 in total

1.  Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude.

Authors:  Kathleen M Carroll; Rajita Sinha; Charla Nich; Theresa Babuscio; Bruce J Rounsaville
Journal:  Exp Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.157

2.  Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Authors:  K M Carroll; S A Ball; C Nich; P G O'Connor; D A Eagan; T L Frankforter; E G Triffleman; J Shi; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2001-08

Review 3.  Consequences of adolescent drug use on psychiatric disorders in early adulthood.

Authors:  J S Brook; L Richter; E Rubenstone
Journal:  Ann Med       Date:  2000-09       Impact factor: 4.709

Review 4.  Multisystemic therapy: a treatment for violent substance-abusing and substance-dependent juvenile offenders.

Authors:  Jeff Randall; Phillippe B Cunningham
Journal:  Addict Behav       Date:  2003-12       Impact factor: 3.913

5.  A comparison of methods for assessing sociopathy in male and female alcoholics.

Authors:  N L Cooney; R M Kadden; M D Litt
Journal:  J Stud Alcohol       Date:  1990-01

6.  Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial.

Authors:  Daniel B Rounsaville; Karen Hunkele; Caroline J Easton; Charla Nich; Kathleen M Carroll
Journal:  J Am Acad Psychiatry Law       Date:  2008

7.  Talk is cheap: measuring drinking outcomes in clinical trials.

Authors:  T F Babor; K Steinberg; R Anton; F Del Boca
Journal:  J Stud Alcohol       Date:  2000-01

8.  Personality and substance use disorders as predictors of criminality.

Authors:  C A Hernandez-Avila; J A Burleson; J Poling; H Tennen; B J Rounsaville; H R Kranzler
Journal:  Compr Psychiatry       Date:  2000 Jul-Aug       Impact factor: 3.735

9.  Intimate partner violence: causes and prevention.

Authors:  Rachel Jewkes
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

10.  Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions.

Authors:  Nena Messina; David Farabee; Richard Rawson
Journal:  J Consult Clin Psychol       Date:  2003-04
View more
  4 in total

Review 1.  Psychosocial interventions for cannabis use disorder.

Authors:  Peter J Gates; Pamela Sabioni; Jan Copeland; Bernard Le Foll; Linda Gowing
Journal:  Cochrane Database Syst Rev       Date:  2016-05-05

Review 2.  The impact of personality disorders on legally supervised community treatment: a systematic literature review.

Authors:  W Amory Carr
Journal:  Community Ment Health J       Date:  2013-09-26

3.  Psychological interventions for antisocial personality disorder.

Authors:  Simon Gibbon; Najat R Khalifa; Natalie H-Y Cheung; Birgit A Völlm; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03

4.  Incentivizing health care behaviors in emerging adults: a systematic review.

Authors:  Catherine H Yu; Giuliana Guarna; Pamela Tsao; Jude R Jesuthasan; Adrian Nc Lau; Ferhan S Siddiqi; Julie Anne Gilmour; Danyal Ladha; Henry Halapy; Andrew Advani
Journal:  Patient Prefer Adherence       Date:  2016-03-24       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.